La criptología de la enfermedad. Luis Alejandro Barrera Avellaneda

1. Finger S, Christ SE. Pearl S. Buck and phenylketonuria (PKU). J Hist Neurosci. 2004/09/17. 2004;13(1):44–57.

2. Centerwall SA, Centerwall WR. The discovery of phenylketonuria: the story of a young couple, two retarded children, and a scientist. Pediatrics. 2000/01/05. 2000;105(1 Pt 1):89–103.

3. Christ SE. Asbjorn Folling and the discovery of phenylketonuria. J Hist Neurosci [Internet]. 2003/06/06. 2003;12(1):44–54. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12785112

      4. Nyhan WL. 50 years ago Asbjorn Folling and phenylketonuria Book Reviews An evolving textbook for undergraduates. 1984;(February):71–2.

5. Nyhan WL. Asbjorn Folling and phenylketonuria. Trends Biochem Sci. 1984;9(2):71–2.

6. Folling A, Sydnes S. A method for the estimation of phenylpyruvic acid in urine with some examples of its use in dietary treatment of phenylpyruvic oligophrenia. Scand J Clin Lab Invest. 1958/01/01. 1958;10(4):355–8.

7. Folling I. The Discovery of PKU | PKU News. In: PKU News. 1994.

8. Folling A. Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Hoppe-Seyler's Zeitschrift für Physiol Chemie. 1934 Jan;227(1–4):169–81.

9. Folling A, Mohr O, Ruud L. Oligophrenia phenylpyrouvica. A recessive syndrome in man... 1945.

10. Jervis G. Phenylpyruvic oligophrenia: Introductory study of fifty cases of mental deficiency associated with excretion of phenylpyruvic acid. Arch Neurol. 1937.

11. Jervis GA. Phenylpiruvic Oligophrenia. Arch Neurol Psychiatry [Internet]. 1937 Nov;38(5):944. Available from: http://archneurpsyc.jamanetwork.com/article.aspx?doi=10.1001/archneurpsyc.1937.02260230042003

12. Penrose L, Quastel JH. Metabolic studies in phenylketonuria. Biochem J. 1937 Feb;31(2):266–74.

13. Jervis GA. Studies on phenylpyruvic oligophrenia; the position of the metabolic error. J Biol Chem. 1947 Aug;169(3):651–6.

14. Jervis GA. Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system. Proc Soc Exp Biol Med. 1953 Mar;82(3):514–5.

15. Bickel H. The first treatment of phenylketonuria. Eur J Pediatr. 1996 Jul;155 Suppl.:S2-3.

      16. Bickel H, Gerrard J, Hickmans EM. Preliminary Communication. Lancet. 1953 Oct;262(6790):812–3.

17. Woolf LI, Griffiths R, Moncrieff A. Treatment of phenylketonuria with a diet low in phenylalanine. Br Med J. 1955/01/08. 1955 Jan;1(4905):57–64.

18. Kaufman S. Phenylalanine hydroxylation cofactor in phenylketonuria. Science. 1958 Dec;128(3337):1506–8.

19. Kaufman S. A new cofactor required for the enzymatic conversion of phenylalanine to tyrosine. JBC. 1958;(4):931–9.

20. Koch R, Acosta P, Ragsdale N, Donnell GN. Nutrition in the Treatment of Phenylketonuria. J Am Diet Assoc. 1963/09/01. 1963;43:212–5.

21. Koch R, Moseley K, Guttler F. Tetrahydrobiopterin and maternal PKU. Mol Genet Metab. 2005;86(SUPPL.).

22. Koch R, Trefz F, Waisbren S. Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab. 2009;99(SUPPL.).

23. Opladen T, Abu Seda B, Rassi A, Thöny B, Hoffmann GF, Blau N. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience. J Inherit Metab Dis [Internet]. 2011 Jun;34(3):819–26. Available from: http://link.springer.com/10.1007/s10545-011-9300-1

24. Van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–56.

25. Surtees R, Blau N. The neurochemistry of phenylketonuria. Eur J Pediatr. 2000;159 Suppl.:S109–13.

26. Blau N. Defining tetrahydrobiopterin (BH4)-responsiveness in PKU. J Inherit Metab Dis. 2008 Feb;31(1):2–3.

27. Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, et al. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc. 2003 Sep;103(9):1167–73.

28. Cotugno G, Nicolò R, Cappelletti S, Goffredo BM, Dionisi Vici C, Di Ciommo V. Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr. 2011;100:1144–9.

29. Schuett VE, Brown ES. Diet policies of PKU clinics in the United States. Am J Public Health. 1984;74(5):501–3.

30. Ney DM, Blank RD, Hansen KE. Advances in the nutritional and pharmacological management of phenylketonuria. Vol. 17, Current Opinion in Clinical Nutrition and Metabolic Care. 2014.

31. Specola N, Chiesa A. Alternative therapies for PKU. J Inborn Errors Metab Screen. 2016;5:1–5.

32. Van Spronsen FJ, De Groot MJ, Hoeksma M, Reijngoud DJ, Van Rijn M. Large neutral amino acids in the treatment of PKU: From theory to practice. Vol. 33, Journal of Inherited Metabolic Disease. 2010. p. 671–6.